Mismatch repair deficient colorectal cancer
Clinical trials for Mismatch repair deficient colorectal cancer explained in plain language.
Never miss a new study
Get alerted when new Mismatch repair deficient colorectal cancer trials appear
Sign up with your email to follow new studies for Mismatch repair deficient colorectal cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Watch and wait: could immunotherapy let some GI cancer patients avoid surgery?
Disease control Recruiting nowThis study looks at people with early-stage gastrointestinal cancers that have a mismatch repair deficiency, a feature that can make tumors respond well to immunotherapy. Part A is a registry that tracks all such patients, whether they have surgery or immunotherapy. Part B follow…
Matched conditions: MISMATCH REPAIR DEFICIENT COLORECTAL CANCER
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill takes on brain tumors and metastases in early trial
Disease control Recruiting nowThis study tests an oral drug called NEO212 in people with specific brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it helps control tumor growth. About 134 adults will take NEO212 alone or with sta…
Matched conditions: MISMATCH REPAIR DEFICIENT COLORECTAL CANCER
Phase 1/2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC